- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01444157
Family and Coping Oriented Palliative Homecare Nursing Aimed at Advanced Cancer Patients (FamCope)
Family and Coping Oriented Palliative Homecare Nursing as a Supplement to Standard Homecare Nursing Aimed at Advanced Cancer Patients - a Randomized Intervention Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Screening for patients will take place in the oncological, gynecological medical, surgical departments of three hospitals in Copenhagen, Denmark among patients diagnosed with cancer. Patients eligible for the study will be informed about the study during hospital admission and asked to participate together with a close relative/family member. When written informed consent has been obtained from both patient and relative they will be asked to fill in questionnaires with background information about sociodemographic data, their physical and psychosocial functioning and quality of life EORTC (QLQ-C30/patient and SF36/relative), their symptoms of anxiety and depression (HAD Scale/patient and relative) and family satisfaction with health care professionals(FamCare/relative). When patients have been discharge from hospital to their own home the families are randomized to control or intervention group. First visit from the research nurse takes place no later than one week after randomization. Visits takes place week 1,4,7,10,13 and 16 after randomization. The questionnaires EORTC QLQ-C30 (patient), HAD Scale (patient and relative), SF 36 (relative) and FamCare (relative) are mailed by post to the families to be answered at week 9, 16 and 24 after randomization. Information about the amount of care the family receives from the municipality (standard homecare) will be obtained from municipal registers. Information about readmissions to hospital are obtained from hospital registers.
The research nurses has a minimum of one year experience within specialised palliative care. The nurses has also participated in a two day course on how to produce and utilise family assessment and have been introduced to the background theory on coping and family nursing.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2100
- Rigshospitalet
-
-
Frederiksberg
-
Copenhagen, Frederiksberg, Denmark, 2000
- Frederiksberg Hopsital
-
-
NV
-
Copenhagen, NV, Denmark, 2400
- Bispebjerg Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
At least one of the following
- Cancer stage 3 or 4 (according to hospital journal)and at least one treatment after relapse without satisfying effect on the disease
- The patient is aware that further treatment is of palliative or life prolonging nature
And also all of following inclusion criterions
- The patient has a family member that would like to participate (The family member must be involved in the patients care at least two times a week)
- At least 18 years old (patient and family member)
- Understand and speak danish (patient and family member)
- Live in the area of the municipalities of Copenhagen or Frederiksberg
- Discharge from hospital to own home
- Written informed consent (patient and family member)
Exclusion Criteria:
- Terminal fase of disease
- Contact with specialised palliative care
- Incapable of co-operating with trial protocol
- Participant in another behavioral intervention study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Palliative homecare nursing group
In addition to the standard homecare nursing the families will receive six home visits from a research nurse with at least 1 year specialised palliative care experience.
During the first 2 hour visit a family assessment is obtained containing identification of family roles, resources and coping strategies.
The first home visit takes place no later than one week after randomization.
The visits continues every third week up to 16 weeks, each visit with a duration of 1,5 hours.
At every visit the EORTC-QLQ-C30 patient administered questionnaire is used to identify the nature, frequency and intensity of the patients physical and psychosocial problems.
|
The nurse helps the family assess the identified problems.
Written coping strategies according to each problem is produced including actions of the patient, family member, nurse or others.
At the same time the nurse keeps attention to the family members specific needs of knowledge and support when handling direct or indirect care, understanding and coping with the disease, treatment, physical, psychosocial and economical problems and the family members own physical and mental health.
The nurse provides knowledge to the family on how to prevent and/or cope with problems that may occur or re-occur and/or accepts or adapt to unsolvable problems.
Other Names:
|
No Intervention: Standard homecare nursing group
Patients continue to receive the standard homecare nursing.
They can contact municipality services for visitation to homecare nursing if they feel that additional homecare is needed or if they do not yet receive this service and feel they need homecare nursing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient reported health related quality of life
Time Frame: Baseline, week 9, week 16 and week 24
|
The change in mean scores from baseline to each follow up as measured in the Quality of life questionnaire EORTC QLQ-C30 scale score(Developed by the European Organization for Research and Treatment of Cancer)in relation to the Global health status scale.
|
Baseline, week 9, week 16 and week 24
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient reported symptoms and problems
Time Frame: Baseline, week 9, week 16 and week 24
|
The change in mean scores from baseline to each follow up as measured in the EORTC QLQ-C30 questionnaire scale score in relation to its functional scales and symptom scales/items.
|
Baseline, week 9, week 16 and week 24
|
Patients symptoms of anxiety and depression
Time Frame: Baseline, week 9, week 16 and week 24
|
The change in mean scores from baseline to each follow up according to the HADS questionnaire (Hospital Anxiety and Depression Scale) Scores are self-reported.
|
Baseline, week 9, week 16 and week 24
|
Family members symptoms of anxiety and depression
Time Frame: Baseline, week 9, week 16, week 24 and 12 months
|
The change in mean scores from baseline to each follow up according to the HADS questionnaire.
Scores are self-reported.
|
Baseline, week 9, week 16, week 24 and 12 months
|
Family members health related quality of life
Time Frame: Baseline, week 9, week 16, week 24 and 12 months
|
The change in mean scores from baseline to each follow up.
Scores are self-reported and measured in the SF36 v1 questionnaire.
|
Baseline, week 9, week 16, week 24 and 12 months
|
Family satisfaction with the health care services provided to the patient
Time Frame: Baseline, week 9, week 16, week 24 and 12 months
|
The change in mean scores from baseline to each follow up.
Scores are self-reported and measured in the FAMCARE questionnaire
|
Baseline, week 9, week 16, week 24 and 12 months
|
Acute readmission to hospital
Time Frame: week 16 and 24
|
The change in mean number of acute readmissions and mean period of hospitalizations (measured in days) from inclusion to the study to week 16 and 24.
Readmissions must be related to the patients cancer disease
|
week 16 and 24
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Susan Rydahl Hansen, Cand.cur, PhD, Research Unit of Clinical Nursing, Bispebjerg Hospital
- Principal Investigator: Anne Birgitte Hjuler Ammari, Cand.scient.san, Research Unit of Clinical Nursing, Bispebjeg Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FamCope2011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Cancer
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
AVEO Pharmaceuticals, Inc.CompletedAdvanced Cancer | Refractory CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
University Health Network, TorontoUniversity of UlmRecruiting
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Canada, Argentina, Chile, Italy
Clinical Trials on Palliative homecare nursing
-
National Taiwan University HospitalRecruiting
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Trondheim KommuneWithdrawnAsthenia | Mobility Limitation
-
Altoosi University CollegeBabylon UniversityUnknownCerebral Palsy | Cancer | HIV/AIDS | Muscular Dystrophy | Cystic Fibrosis | Cardiac Anomaly | Batten's DiseaseIraq
-
Shanxi Medical UniversityRecruitingChronic Kidney Diseases | Maintenance Hemodialysis | Narrative NursingChina
-
Massachusetts General HospitalPatient-Centered Outcomes Research InstituteRecruitingHigh Risk Acute Myeloid Leukemia | Relapsed Adult AML | Primary Refractory Acute Myeloid LeukemiaUnited States
-
Hopital of MelunCompletedCritical Ill Patients | Ventilated PatientsFrance
-
Nantes University HospitalTerminatedOncology, GerontologyFrance
-
Allina Health SystemCompleted
-
Heart and Diabetes Center North-Rhine WestfaliaMartin-Luther-Universität Halle-WittenbergCompleted
-
Mehtap GümüşayCompletedQuality of Life | Nursing Caries | Surgical MenopauseTurkey